Determination of the Starting dose for Acute Oral Toxicity (LD50) Testing in the up and down Procedure (UDP) from Cytotoxicity Data

Abstract

To reduce the number of animals used in acute oral toxicity testing, cytotoxicity data (IC50) can be used to determine the starting dose for in vivo testing by applying the standard regression between IC50 and acute oral LD50 values in the Register of Cytotoxicity (RC). In the RC, the correlation between cytotoxicity, represented by the mean IC50 (IC50x), and the acute oral LD50 of rats and/or mice has been determined for 347 chemicals by applying the linear regression model for log-transformed pairs of IC50 versus oral LD50. The standard regression line of the two toxicity parameters is characterised by an intercept a = 0.625 and regression coefficient b = 0.435, and 252 of 347 chemicals (72.6 %) are located within a dose-range differing by not more than 0.699 (factor F_G ≤ log 5) from the standard regression line. In the present study, we have used the RC and its IC50/LD50 regression model to predict the LD50 values from cytotoxicity data for nine chemicals which were tested in an evaluation study of the Up and Down Procedure (UDP). For seven of the nine chemicals, LD50 values (mg/kg) predicted from the RC were in the same dose-range as LD50 values determined in vivo, while the dose-range differed by more than one order of magnitude for the two remaining chemicals. Thus, the prediction of LD50 values from cytotoxicity data was promising in this limited data set. It is proposed that a tiered in vitro/in vivo testing approach will reduce animal use in the UDP method. As the first step, the in vitro cytotoxicity of a new chemical is determined. By applying the RC regression and adapting it to the sensitivity of a specific cell line, the LD50 value (mg/kg) can be predicted from the IC50 value. The predicted LD50 dose is then used as the starting dose in the UDP. In the RC model, the precision of the prediction increases with decreasing toxic potential, and the majority of industrial chemicals (around 90%) are not toxic according to EU classification criteria.

Keywords

acute oral toxicity LD50 Up and Down Procedure UDP Register of Cytotoxicity RC cell lines cytotoxicity IC50

Get full access to this article

View all access options for this article.

References

Halle

(1985). Grundlagen der Zytotoxizität in vitro und ihre Bedeutung für die toxikologische Prüfung von Antiseptika. In Handbuch der Antiseptik, Vol. I, 5, Grundlagen der Antiseptik. Toxische und allergische Nebenwirkungen von Antiseptika (ed. Kramer

, Berencsi

, & Weuffen

), pp. 84–112. Berlin, Germany: Volk und Gesundheit.

Halle

, & Goeres

(1988). Register der Zytotoxizität (IC50) in der Zellkultur und Möglichkeiten zur Abschätzung der akuten Toxizität (LD50). In Beiträge zur Wirkstoffforschung (ed. Oehme

, Loewe

, & Goeres

), 108 pp. Berlin, Germany: Institut für Wirkstoff-forschung.

Halle

, & Spielmann

(1992). Two procedures for the prediction of acute toxicity (LD50) from cytotoxicity data. ATLA 20, 40–49.

Halle

, & Spielmann

(1997). Die Prädiktion der akuten Toxizität mit Hilfe von Zytotoxizitätsdaten. In Forschung ohne Tierversuche 1996 (ed. Schöffl

, Spielmann

, Tritthart

H.A.

, Cussler

, Goetschel

A.F.

, Gruber

F.P.

, & Reinhardt

C.A.

), pp. 10–19. Wien, Austria: Springer.

Halle

(1998). Toxizitätsprüfungen in Zellkulturen für eine Vorhersage der akuten Toxizität (LD50) zur Einsparung von Tierversuchen. Life Sciences/Lebens-wissenschaften, Vol. 1, 94 pp. Jülich: Forschungszentrum Jülich.

Halle

, Liebsch

, Traue

, & Spielmann

(1997). Reduktion der Tierzahlen bei der Einstufung von Stoffen in die EU-Toxizitätsklassen für akute orale Toxizität mit Hilfe von Daten aus dem Register der Zytotoxizität (RC). Alternativen zu Tierexperimenten. ALTEX 14, 8–15.

OECD (1996). OECD Guidelines for the Testing of Chemicals, No. 423: Acute Oral Toxicity — Acute Toxic Class Method. 15 pp. Paris, France: OECD.

Bruce

R.B.

(1985). An Up-and-Down Procedure for acute toxicity testing. Fundamental and Applied Toxicology 5, 151–157.

Tatken

R.L.

, & Lewis

R.J.

eds (1984). Registry of Toxic Effects of Chemical Substances, 1981-82 Edn, Vol. 1–3, 1983, and 1983 Supplement Vol. 1 and 2, 1984. Ohio, CN, USA: US Department of Health and Human Services.

10.

Halle

, & Spielmann

(1992). Zur Qualität der Vorhersage der akuten Toxizität (LD50) aus der Zytotoxizität IC50x für eine Gruppe von 26 Neuroleptika aufgrund der Daten des “Erweiterten Registers dr Zytotoxizität”. Alternativen zu Tierexperimenten. ALTEX 11, 148–153.

11.

OECD (1998). OECD Guidelines for the Testing of Chemicals No. 425: Acute Oral Toxicity — Up-and-Down Procedure. 8 pp. Paris, France: OECD.

12.

Lipnick

R.L.

, Cotruvo

J.A.

, Hill

R.N.

, Bruce

R.D.

, Stitzel

K.A.

, Walker

A.P.

, Chu

, Goddard

, Segal

, Springer

J.A.

, & Myers

R.C.

(1995). Comparison of the Up-and-Down, Conventional LD50 and Fixed Dose Acute Toxicity Procedures. Food and Chemical Toxicology 33, 223–231.

13.

Ekwall

(1983). Correlation between cytotoxicity in vitro and LD50 values. Acta Pharmacologica et Toxicologica 52, 80–99.

14.

Ekwall

, Clemedson

, Crafoord

, Ekwall

, Hallander

, Walum

, & Bondesson

(1998). MEIC: evaluation of acute systemic toxicity. Part V. Rodent and human toxicity data for the 50 reference chemicals. ATLA 26, 571–616.

15.

Ekwall

(1998). MEIC: evaluation of acute systemic toxicity. Part VI. The prediction of human toxicity by rodent LD50 values and results from 61 in vitro methods. ATLA 26, 617–658.

16.

Clothier

R.H.

, Hulme

L.M.

, Smith

, & Balls

(1987). Comparison of the in vitro cytotoxicities and acute in vivo toxicity of 59 chemicals. Molecular Toxicology 1, 571–577.

17.

Balls

, & Fentem

J.H.

(1992). The use of basal cytotoxicity and target organ toxicity tests in hazard identification and risk management. ATLA 20, 368–388.

18.

Seibert

, Balls

, Fentem

J.H.

, Bianchi

, Clothier

R.H.

, Dierickx

P.J.

, Ekwall

, Garle

M.J.

, Gómez-Lechón

M.J.

, Gribaldo

, Gülden

, Liebsch

, Rasmussen

, Roguet

, Shrivastava

, & Walum

(1996). Acute toxicity testing in vitro and the classification and labelling of chemicals. The report and recommendations of ECVAM workshop 16. ATLA 24, 499–510.

19.

Ekwall

, Clemedson

, Ekwall

, Ring

, & Romert

(1999). EDIT: A new international multicentre programme to develop and evaluate batteries of in vitro tests for acute and chronic systemic toxicity. ATLA 27, 339–349.

20.

Knox

, Uphill

P.F.

, Fry

J.R.

, Benford

, & Balls

(1986). The FRAME multicentre project on in vitro cytotoxicity. Food and Chemical Toxicology 24, 457–463.

21.

Clothier

R.H.

, Hulme

L.M.

, Ahmed

A.B.

, Reeves

H.L.

, Smith

, & Balls

(1988). In vitro cytotoxicity of 150 chemicals to 3T3-1 cells assessed by the FRAME kenacid blue method. ATLA 16, 84–95.

22.

Anon. (1993). Annexes I, II, III and IV to Commission Directive 93/21/EEC of 27 April 1993 adapting to technical progress for the 18th time Council Directive 67/548/EEC on the approximation of laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances. Official Journal of the European Communities L110A, 1–86.